These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7923664)

  • 1. Independent control of skin and muscle sympathetic nerve activity in patients with heart failure.
    Middlekauff HR; Hamilton MA; Stevenson LW; Mark AL
    Circulation; 1994 Oct; 90(4):1794-8. PubMed ID: 7923664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of low-frequency variability of sympathetic nerve activity in severe heart failure.
    van de Borne P; Montano N; Pagani M; Oren R; Somers VK
    Circulation; 1997 Mar; 95(6):1449-54. PubMed ID: 9118512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tonic chemoreflex activation does not contribute to elevated muscle sympathetic nerve activity in heart failure.
    van de Borne P; Oren R; Anderson EA; Mark AL; Somers VK
    Circulation; 1996 Sep; 94(6):1325-8. PubMed ID: 8822987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential distribution of muscle and skin sympathetic nerve activity in patients with end-stage renal disease.
    Park J; Campese VM; Nobakht N; Middlekauff HR
    J Appl Physiol (1985); 2008 Dec; 105(6):1873-6. PubMed ID: 18845779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure.
    Kingwell BA; Thompson JM; Kaye DM; McPherson GA; Jennings GL; Esler MD
    Circulation; 1994 Jul; 90(1):234-40. PubMed ID: 8026003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enalaprilat augments arterial and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with heart failure.
    Dibner-Dunlap ME; Smith ML; Kinugawa T; Thames MD
    J Am Coll Cardiol; 1996 Feb; 27(2):358-64. PubMed ID: 8557906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of heart failure on baroreflex control of sympathetic neural activity.
    Ferguson DW; Berg WJ; Roach PJ; Oren RM; Mark AL
    Am J Cardiol; 1992 Feb; 69(5):523-31. PubMed ID: 1736618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation between muscle and skin sympathetic nerve activity in essential hypertension, obesity, and congestive heart failure.
    Grassi G; Colombo M; Seravalle G; Spaziani D; Mancia G
    Hypertension; 1998 Jan; 31(1):64-7. PubMed ID: 9449392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure.
    Leimbach WN; Wallin BG; Victor RG; Aylward PE; Sundlöf G; Mark AL
    Circulation; 1986 May; 73(5):913-9. PubMed ID: 3698236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II--nitric oxide interactions in the control of sympathetic outflow in heart failure.
    Zucker IH; Liu JL
    Heart Fail Rev; 2000 Mar; 5(1):27-43. PubMed ID: 16228914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure.
    Grassi G; Seravalle G; Cattaneo BM; Lanfranchi A; Vailati S; Giannattasio C; Del Bo A; Sala C; Bolla GB; Pozzi M
    Circulation; 1995 Dec; 92(11):3206-11. PubMed ID: 7586305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial baroreceptor and cardiopulmonary reflex control of sympathetic outflow in human heart failure.
    Floras JS
    Ann N Y Acad Sci; 2001 Jun; 940():500-13. PubMed ID: 11458705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure.
    Ligtenberg G; Blankestijn PJ; Oey PL; Klein IH; Dijkhorst-Oei LT; Boomsma F; Wieneke GH; van Huffelen AC; Koomans HA
    N Engl J Med; 1999 Apr; 340(17):1321-8. PubMed ID: 10219067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baroreflex control of muscle sympathetic nerve activity in borderline hypertension.
    Rea RF; Hamdan M
    Circulation; 1990 Sep; 82(3):856-62. PubMed ID: 2394007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sympathetic activation in human heart failure: diverse mechanisms, therapeutic opportunities.
    Floras JS
    Acta Physiol Scand; 2003 Mar; 177(3):391-8. PubMed ID: 12609011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of sympathetic nerve activity by vagal mechanoreflexes is blunted in heart failure.
    Dibner-Dunlap ME; Thames MD
    Circulation; 1992 Dec; 86(6):1929-34. PubMed ID: 1451264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiorenal anemia syndrome in chronic heart failure contributes to increased sympathetic nerve activity.
    Franchitto N; Despas F; Labrunee M; Vaccaro A; Lambert E; Lambert G; Galinier M; Senard JM; Pathak A
    Int J Cardiol; 2013 Oct; 168(3):2352-7. PubMed ID: 23415171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morning sympathetic nerve activity is not increased in humans. Implications for mechanisms underlying the circadian pattern of cardiac risk.
    Middlekauff HR; Sontz EM
    Circulation; 1995 May; 91(10):2549-55. PubMed ID: 7743616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application of microneurography to circulatory disorders].
    Asanoi H
    Brain Nerve; 2009 Mar; 61(3):270-6. PubMed ID: 19301597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased cardiac sympathetic nerve activity in heart failure is not due to desensitization of the arterial baroreflex.
    Watson AM; Hood SG; Ramchandra R; McAllen RM; May CN
    Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H798-804. PubMed ID: 17434976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.